Michael Klobuchar - Apr 30, 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
EVP - Chief Strategy Officer
Signature
/s/ Kelly E. W. Grez, attorney-in-fact for Michael Klobuchar
Stock symbol
MRK
Transactions as of
Apr 30, 2024
Transactions value $
$0
Form type
4
Date filed
5/2/2024, 04:09 PM
Previous filing
Feb 16, 2024
Next filing
May 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 23.2K Apr 30, 2024 Direct F1
holding MRK Common Stock 6.29 Apr 30, 2024 By Child
holding MRK Common Stock 6.29 Apr 30, 2024 By Child
holding MRK Common Stock - 401(k) Plan 867 Apr 30, 2024 By 401(k) F2
holding MRK Common Stock - 401(k) Plan 697 Apr 30, 2024 By Spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +20.5K $0.00 20.5K Apr 30, 2024 Common Stock 20.5K $129.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
F3 The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.